Semler Scientific, Inc.
SMLR
$33.60
$0.802.44%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -17.56% | -17.19% | -22.25% | -12.65% | 9.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.56% | -17.19% | -22.25% | -12.65% | 9.15% |
| Cost of Revenue | 21.23% | 4.05% | 2.95% | -1.73% | -23.10% |
| Gross Profit | -20.05% | -18.74% | -24.02% | -13.47% | 12.17% |
| SG&A Expenses | -13.67% | -14.41% | -23.97% | -27.72% | 2.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.61% | -10.31% | -20.22% | -25.30% | -2.50% |
| Operating Income | -31.00% | -26.57% | -25.49% | 11.51% | 41.91% |
| Income Before Tax | 1,057.64% | -8.77% | -85.17% | 17.55% | -28.89% |
| Income Tax Expenses | 339.52% | -48.03% | -36.99% | 3.61% | -289.88% |
| Earnings from Continuing Operations | 591.92% | 1.72% | -99.81% | 22.22% | 31.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 591.92% | 1.72% | -99.81% | 22.22% | 31.25% |
| EBIT | -31.00% | -26.57% | -25.49% | 11.51% | 41.91% |
| EBITDA | -30.84% | -27.06% | -25.25% | 12.01% | 41.95% |
| EPS Basic | 486.07% | -3.01% | -99.82% | 18.83% | 29.07% |
| Normalized Basic EPS | 371.50% | -19.88% | -87.47% | 12.47% | 45.43% |
| EPS Diluted | 534.57% | 1.41% | -99.81% | 23.81% | 31.49% |
| Normalized Diluted EPS | 402.58% | -15.47% | -86.91% | 17.38% | 51.42% |
| Average Basic Shares Outstanding | 18.06% | 4.88% | 3.54% | 2.86% | 1.70% |
| Average Diluted Shares Outstanding | 10.76% | -0.60% | -0.91% | -1.44% | -2.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
